Key result
Exposure to high, low, or alternating glucose accelerated the appearance of endothelial cell senescence markers (by ~PDL 35 and ~PDL 18, respectively) compared to normal glucose (~PDL 44).
Why the study?
Does exposure to high, low, or alternating glucose levels accelerate endothelial cell senescence and dysregulate nitric oxide synthase in a human umbilical vein endothelial cell model?
Does exposure to high, low, or alternating glucose levels accelerate endothelial cell senescence and dysregulate nitric oxide synthase in a human umbilical vein endothelial cell model?
Exposure to abnormal glucose levels (high, low, or alternating) accelerates endothelial cell senescence and eNOS dysregulation in vitro, providing mechanistic insight into endothelial dysfunction associated with glucose intolerance.
No takes yet. Share an insight, caveat, or question.
In vitro endothelial senescence data require cautious clinical translation; leaves open in vivo validation of age-glucose interactions in vascular aging.
Rogers et al. (2013) studied Endothelial cell senescence and glucose stress. High (25 mM), low (1.5 mM), or alternating glucose vs. Normal glucose (5.5 mM) was evaluated on Appearance of markers of cell senescence and endothelial nitric oxide synthase expression and activity. Exposure to high, low, or alternating glucose accelerated the appearance of endothelial cell senescence markers (by ~PDL 35 and ~PDL 18, respectively) compared to normal glucose (~PDL 44).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: